NCT01963845View on ClinicalTrials.gov

Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Non-alcoholic Fatty Liver Disease
Interventions
DRUG

Sitagliptin

DRUG

Placebo

Trial Locations (1)

92103

University of California, San Diego, San Diego

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT01963845 - Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver Disease | Biotech Hunter | Biotech Hunter